دورية أكاديمية
Checkpoint Inhibitor-Associated Vogt-Koyanagi-Harada Disease Presenting 3 Months Following Discontinuation of Nivolumab.
| العنوان: | Checkpoint Inhibitor-Associated Vogt-Koyanagi-Harada Disease Presenting 3 Months Following Discontinuation of Nivolumab. |
|---|---|
| المؤلفون: | Tieger MG, Eliott D, Cakir B, Dahrouj M |
| المصدر: | Ophthalmic surgery, lasers & imaging retina [Ophthalmic Surg Lasers Imaging Retina] 2023 Mar; Vol. 54 (3), pp. 183-187. Date of Electronic Publication: 2023 Mar 01. |
| نوع المنشور: | Case Reports; Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Healio.com Country of Publication: United States NLM ID: 101599215 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2325-8179 (Electronic) Linking ISSN: 23258160 NLM ISO Abbreviation: Ophthalmic Surg Lasers Imaging Retina Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: <2013-> : Thorofare, NJ : Healio.com Original Publication: Thorofare, NJ : Slack Incorporated [2013- ] |
| مواضيع طبية MeSH: | Nivolumab*/adverse effects , Uveomeningoencephalitic Syndrome*/chemically induced , Uveomeningoencephalitic Syndrome*/diagnosis , Uveomeningoencephalitic Syndrome*/drug therapy , Immune Checkpoint Inhibitors*/adverse effects, Humans ; Male ; Middle Aged ; Carcinoma, Renal Cell/drug therapy ; Carcinoma, Renal Cell/complications ; Eye ; Kidney Neoplasms/drug therapy ; Kidney Neoplasms/complications |
| مستخلص: | The use of checkpoint inhibitors has been associated with multiple ocular and orbital complications including Vogt-Koyanagi-Harada disease. In the current case, a 55-year-old man presented with visual changes 3 months following discontinuation of nivolumab for metastatic renal cell carcinoma. This is the second report of delayed presentation following discontinuation of a checkpoint inhibitor and the only case not associated with an alternative targeted therapy at the time of presentation. This article highlights a unique presentation of delayed checkpoint inhibitor-associated Vogt-Koyanagi-Harada and summarizes the reported cases. [ Ophthalmic Surg Lasers Imaging Retina 2023;54(3):183-187.] . |
| المشرفين على المادة: | 31YO63LBSN (Nivolumab) 0 (Immune Checkpoint Inhibitors) |
| تواريخ الأحداث: | Date Created: 20230321 Date Completed: 20230817 Latest Revision: 20230817 |
| رمز التحديث: | 20240628 |
| DOI: | 10.3928/23258160-20230221-06 |
| PMID: | 36944065 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 2325-8179 |
|---|---|
| DOI: | 10.3928/23258160-20230221-06 |